School of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Departamento de Medicina general, Unidad de Medicina Familiar No. 21, IMSS, La Cruz de Elota, Sinaloa, Mexico.
Clin Respir J. 2024 Jul;18(7):e13813. doi: 10.1111/crj.13813.
The objective of this study was to associate the epidemiological and clinical characteristics of patients hospitalized for COVID-19 with the progression to critical illness and death in northwestern Mexico.
From March to October 2020, we collected the demographic and clinical characteristics of 464 hospitalized patients from northwestern Mexico.
Sixty-four percent (295/464) of the patients became critically ill. Age, occupation, steroid and antibiotic use at previous hospitalization, and underlying diseases (hypertension, obesity, and chronic kidney disease) were associated with critical illness or death (p: < 0.05). No symptoms were associated with critical illness. However, the parameters such as the heart rate, respiratory rate, oxygen saturation, and diastolic pressure and the laboratory parameters such as the glucose, creatinine, white line cells, hemoglobin, D-dimer, and C-reactive protein, among others, were associated with critical illness (p: < 0.05). Finally, advanced age, previous hospital treatment, and the presence of one or more underlying diseases were associated with critical illness and death (p: < 0.02).
Several epidemiological (e.g., age and occupation) and clinical factors (e.g., previous treatment, underlying diseases, and vital signs and laboratory parameters) were associated with critical illness and death in patients hospitalized with COVID-19. These data provide us with possible markers to avoid critical illness or death from COVID-19 in our region.
本研究旨在将墨西哥西北部因 COVID-19 住院患者的流行病学和临床特征与发展为危重症和死亡的情况联系起来。
2020 年 3 月至 10 月,我们收集了来自墨西哥西北部的 464 名住院患者的人口统计学和临床特征。
64%(295/464)的患者病情恶化。年龄、职业、之前住院时使用类固醇和抗生素以及潜在疾病(高血压、肥胖症和慢性肾病)与危重症或死亡相关(p:<0.05)。没有症状与危重症相关。然而,心率、呼吸频率、血氧饱和度和舒张压以及实验室参数(如葡萄糖、肌酐、白细胞、血红蛋白、D-二聚体和 C 反应蛋白等)等参数与危重症相关(p:<0.05)。最后,年龄较大、之前住院治疗以及存在一种或多种潜在疾病与危重症和死亡相关(p:<0.02)。
一些流行病学因素(如年龄和职业)和临床因素(如之前的治疗、潜在疾病以及生命体征和实验室参数)与 COVID-19 住院患者的危重症和死亡相关。这些数据为我们提供了可能的标志物,以便在我们所在地区避免 COVID-19 导致的危重症或死亡。